Intermediate
Technical
In the Industry Vocabulary Test
dual antiplatelet therapy
Combined use of aspirin and P2Y12 inhibitor to prevent stent thrombosis and reduce ischemic events.
Full Definition
Dual antiplatelet therapy (DAPT) involves the concurrent administration of aspirin and a P2Y12 receptor inhibitor such as clopidogrel, prasugrel, or ticagrelor to provide enhanced platelet inhibition. DAPT is the standard of care following percutaneous coronary intervention with stent placement to prevent stent thrombosis and reduce major adverse cardiovascular events. Duration of therapy varies based on stent type, indication, and bleeding risk assessment, typically ranging from one month to several years.
Usage
Usage note: Specify drug names and duration when documenting prescription details.
In Context
- "The patient was prescribed dual antiplatelet therapy for twelve months following drug-eluting stent implantation." — Discharge planning
- "Dual antiplatelet therapy was continued for an extended duration due to high thrombotic risk." — Follow-up visit note
Also known as
DAPT
Contrasted with
monotherapy
single antiplatelet therapy
Don't confuse with
triple therapy
anticoagulation